Market Forecast By Product (Neomycin, Tobramycin, Gentamicin, Amikacin, Paromomycin, Streptomycin, Kanamycin, Others), By Route of Administration (Injectables (Parenteral), Feed, Intra-mammary, Topical, Oral), By Application (Veterinary, Skin Infection, Respiratory diseases, UTI & Pelvic Diseases, Other diseases) And Competitive Landscape
| Product Code: ETC312090 | Publication Date: Aug 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The Vietnam Aminoglycosides Market is projected to witness mixed growth rate patterns during 2025 to 2029. The growth rate begins at 10.26% in 2025, climbs to a high of 11.89% in 2027, and moderates to 10.56% by 2029.

The Aminoglycosides market in Vietnam is projected to grow at a high growth rate of 11.89% by 2027, highlighting the country's increasing focus on advanced technologies within the Asia region, where China holds the dominant position, followed closely by India, Japan, Australia and South Korea, shaping overall regional demand.

In the pharmaceutical landscape of Vietnam, the aminoglycosides market is witnessing growth, driven by the rising prevalence of bacterial infections. Aminoglycosides, known for their broad-spectrum antibacterial activity, are widely used in the treatment of severe infections. The market is characterized by the presence of key pharmaceutical companies investing in research and development to introduce advanced aminoglycoside formulations. The increasing healthcare infrastructure and awareness about infectious diseases contribute to the positive trajectory of the aminoglycosides market in Vietnam.
The Vietnam Aminoglycosides market is witnessing robust growth driven by several key factors. Increased prevalence of bacterial infections and rising demand for effective antibiotics in the healthcare sector are primary drivers. Aminoglycosides, known for their broad-spectrum antibacterial properties, have become indispensable in treating severe infections. The growing awareness among healthcare professionals about the efficacy of aminoglycosides further fuels market expansion. Additionally, the rising geriatric population, susceptible to various infections, contributes to the increased adoption of aminoglycosides.
The Vietnam Aminoglycosides Market grapples with challenges related to antibiotic resistance and the need for continuous research and development. The market must address concerns about the overuse of aminoglycosides leading to resistance, requiring a delicate balance between their effectiveness and responsible use. Regulatory scrutiny and the demand for stringent quality control also pose challenges for manufacturers. The market needs to invest in innovation and collaborate with healthcare stakeholders to address emerging health threats while ensuring the sustainability of aminoglycoside usage.
The Vietnam Aminoglycosides Market experienced disruptions due to the COVID-19 pandemic, affecting the pharmaceutical industry`s supply chain. The increased demand for critical healthcare products strained production capacities. Market participants responded by enhancing manufacturing capabilities and exploring collaborations to address supply chain vulnerabilities. The market is now evolving with a renewed emphasis on healthcare infrastructure and pharmaceutical research and development.
In the Vietnam Aminoglycosides market, key players such as Domesco Medical Import-Export Joint Stock Corporation, Traphaco Joint Stock Company, and DHG Pharmaceutical Joint Stock Company are pivotal in the production and distribution of aminoglycoside antibiotics. These companies are recognized for their commitment to pharmaceutical excellence, ensuring the availability of essential medications in the Vietnamese healthcare sector and contributing to the overall well-being of the population.
| 1 Executive Summary |
| 2 Introduction |
| 2.1 Key Highlights of the Report |
| 2.2 Report Description |
| 2.3 Market Scope & Segmentation |
| 2.4 Research Methodology |
| 2.5 Assumptions |
| 3 Vietnam Aminoglycosides Market Overview |
| 3.1 Vietnam Country Macro Economic Indicators |
| 3.2 Vietnam Aminoglycosides Market Revenues & Volume, 2021 & 2031F |
| 3.3 Vietnam Aminoglycosides Market - Industry Life Cycle |
| 3.4 Vietnam Aminoglycosides Market - Porter's Five Forces |
| 3.5 Vietnam Aminoglycosides Market Revenues & Volume Share, By Product, 2021 & 2031F |
| 3.6 Vietnam Aminoglycosides Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
| 3.7 Vietnam Aminoglycosides Market Revenues & Volume Share, By Application, 2021 & 2031F |
| 4 Vietnam Aminoglycosides Market Dynamics |
| 4.1 Impact Analysis |
| 4.2 Market Drivers |
| 4.2.1 Increasing prevalence of bacterial infections in Vietnam |
| 4.2.2 Growing awareness about the effectiveness of aminoglycosides in treating severe infections |
| 4.2.3 Rising healthcare expenditure in Vietnam |
| 4.3 Market Restraints |
| 4.3.1 Rising concern over antibiotic resistance |
| 4.3.2 Availability of alternative treatment options |
| 4.3.3 Stringent regulations governing the use of antibiotics |
| 5 Vietnam Aminoglycosides Market Trends |
| 6 Vietnam Aminoglycosides Market, By Types |
| 6.1 Vietnam Aminoglycosides Market, By Product |
| 6.1.1 Overview and Analysis |
| 6.1.2 Vietnam Aminoglycosides Market Revenues & Volume, By Product, 2021-2031F |
| 6.1.3 Vietnam Aminoglycosides Market Revenues & Volume, By Neomycin, 2021-2031F |
| 6.1.4 Vietnam Aminoglycosides Market Revenues & Volume, By Tobramycin, 2021-2031F |
| 6.1.5 Vietnam Aminoglycosides Market Revenues & Volume, By Gentamicin, 2021-2031F |
| 6.1.6 Vietnam Aminoglycosides Market Revenues & Volume, By Amikacin, 2021-2031F |
| 6.1.7 Vietnam Aminoglycosides Market Revenues & Volume, By Paromomycin, 2021-2031F |
| 6.1.8 Vietnam Aminoglycosides Market Revenues & Volume, By Streptomycin, 2021-2031F |
| 6.1.9 Vietnam Aminoglycosides Market Revenues & Volume, By Others, 2021-2031F |
| 6.1.10 Vietnam Aminoglycosides Market Revenues & Volume, By Others, 2021-2031F |
| 6.2 Vietnam Aminoglycosides Market, By Route of Administration |
| 6.2.1 Overview and Analysis |
| 6.2.2 Vietnam Aminoglycosides Market Revenues & Volume, By Injectables (Parenteral), 2021-2031F |
| 6.2.3 Vietnam Aminoglycosides Market Revenues & Volume, By Feed, 2021-2031F |
| 6.2.4 Vietnam Aminoglycosides Market Revenues & Volume, By Intra-mammary, 2021-2031F |
| 6.2.5 Vietnam Aminoglycosides Market Revenues & Volume, By Topical, 2021-2031F |
| 6.2.6 Vietnam Aminoglycosides Market Revenues & Volume, By Oral, 2021-2031F |
| 6.3 Vietnam Aminoglycosides Market, By Application |
| 6.3.1 Overview and Analysis |
| 6.3.2 Vietnam Aminoglycosides Market Revenues & Volume, By Veterinary, 2021-2031F |
| 6.3.3 Vietnam Aminoglycosides Market Revenues & Volume, By Skin Infection, 2021-2031F |
| 6.3.4 Vietnam Aminoglycosides Market Revenues & Volume, By Respiratory diseases, 2021-2031F |
| 6.3.5 Vietnam Aminoglycosides Market Revenues & Volume, By UTI & Pelvic Diseases, 2021-2031F |
| 6.3.6 Vietnam Aminoglycosides Market Revenues & Volume, By Other diseases, 2021-2031F |
| 7 Vietnam Aminoglycosides Market Import-Export Trade Statistics |
| 7.1 Vietnam Aminoglycosides Market Export to Major Countries |
| 7.2 Vietnam Aminoglycosides Market Imports from Major Countries |
| 8 Vietnam Aminoglycosides Market Key Performance Indicators |
8.1 Number of prescriptions for aminoglycosides |
8.2 Percentage of aminoglycoside-resistant bacterial strains |
8.3 Investment in research and development of new aminoglycoside formulations |
8.4 Adoption rate of aminoglycosides in hospitals and healthcare facilities |
| 9 Vietnam Aminoglycosides Market - Opportunity Assessment |
| 9.1 Vietnam Aminoglycosides Market Opportunity Assessment, By Product, 2021 & 2031F |
| 9.2 Vietnam Aminoglycosides Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
| 9.3 Vietnam Aminoglycosides Market Opportunity Assessment, By Application, 2021 & 2031F |
| 10 Vietnam Aminoglycosides Market - Competitive Landscape |
| 10.1 Vietnam Aminoglycosides Market Revenue Share, By Companies, 2024 |
| 10.2 Vietnam Aminoglycosides Market Competitive Benchmarking, By Operating and Technical Parameters |
| 11 Company Profiles |
| 12 Recommendations |
| 13 Disclaimer |